News of Note—Pfizer, Serum Institute and more

In this week's vaccine News of Note, Pfizer reported third quarter results.

Here is some other vaccine news of note for this week.

> Pfizer reported vaccine sales that were up 1% over the same period last year. Key pneumococcal shot Prevnar 13 slipped by 1%. Release (PDF)

> Serum Institute of India hopes to more than double its revenue in the next five years and is eyeing sales in the U.S. in Europe. Economic Times story

> The CDC's Advisory Committee on Immunization Practices recommended a third dose of a mumps-containing vaccine for those at risk during an outbreak. Washington Post story